Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |